Quantum Biopharma Class B Subordinate Voting Shares
QNTM
14 hedge funds and large institutions have $714K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
2,660% more call options, than puts
Call options by funds: $276K | Put options by funds: $10K
60% more capital invested
Capital invested by funds: $445K → $714K (+$269K)
0% more funds holding
Funds holding: 14 → 14 (0)
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$29.4K |
| 2 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
+$13.2K |
| 3 |
Renaissance Technologies
New York
|
+$13K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$10.4K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$772 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$114K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$25.7K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$24.1K |
| 4 |
Jane Street
New York
|
-$19.2K |
| 5 |
Rockefeller Capital Management
New York
|
-$3K |
QNTM Hedge Fund Activity: Q1 2023 in Review
14 of the 6,277 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q1 2023, worth a combined $714K — up 60% from $445K a quarter earlier.
Fund positioning in QNTM was balanced in Q1 2023: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 4 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $29.4K. The largest seller was AdvisorShares Investments, cutting an estimated $114K.
- 14 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $714K of Quantum Biopharma Class B Subordinate Voting Shares stock for Q1 2023, up 60% quarter-over-quarter.
- 3 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q1 2023 and 3 closed out, a net change of 0 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q1 2023 was Two Sigma Securities, an estimated $29.4K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q1 2023 was AdvisorShares Investments, an estimated $114K sold.
Based on aggregated 13F filings for Q1 2023.